The following pages link to Hajime Uno (Q61025):
Displaying 6 items.
- A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials (Q61028) (← links)
- On assessing survival benefit of immunotherapy using long‐term restricted mean survival time (Q61029) (← links)
- survRM2adapt (Q61030) (← links)
- Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy (Q80990) (← links)
- survAH (Q80991) (← links)
- On permutation tests for comparing restricted mean survival time with small sample from randomized trials (Q137464) (← links)
